Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Aliberti S, Ringshausen FC, Dhar R, Haworth CS, Loebinger MR, Dimakou K, Crichton ML, De Soyza A, Vendrell M, Burgel PR, McDonnell M, Skrgat S, Maiz Carro L, de Roux A, Sibila O, Bossios A, van der Eerden M, Kauppi P, Wilson R, Milenkovic B, Menendez R, Murris M, Borekci S, Munteanu O, Obradovic D, Nowinski A, Amorim A, Torres A, Lorent N, Van Braeckel E, Altenburg J, Shoemark A, Shteinberg M, Boersma W, Goeminne PC, Elborn JS, Hill AT, Welte T, Blasi F, Polverino E, Chalmers JD; EMBARC Registry Investigators.
Eur Respir J. 2024 Apr 18;63(4):2301554. doi: 10.1183/13993003.01554-2023. Print 2024 Apr.
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O'Donnell A, Aksamit T; EMBARC/BRR definitions working group.
Eur Respir J. 2017 Jun 8;49(6):1700051. doi: 10.1183/13993003.00051-2017. Print 2017 Jun.
Sputum handling for rheology.
Esteban Enjuto L, Robert de Saint Vincent M, Maurin M, Degano B, Bodiguel H.
Sci Rep. 2023 May 11;13(1):7695. doi: 10.1038/s41598-023-34043-9.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA.
Ann Intern Med. 1987 Feb;106(2):196-204. doi: 10.7326/0003-4819-106-2-196.
Bronchiectasis.
ten Hacken N, Kerstjens H, Postma D.
BMJ Clin Evid. 2008 Jan 2;2008:1507.
Identification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia.
Ito A, Ishida T, Tachibana H, Nakanishi Y, Kawataki M, Yamazaki A, Washio Y.
J Clin Microbiol. 2024 Apr 10;62(4):e0166523. doi: 10.1128/jcm.01665-23. Epub 2024 Mar 19.
Most of the lipid in purulent sputum is bound to mucus glycoprotein.
Nadziejko CE, Slomiany BL, Slomiany A.
Exp Lung Res. 1993 Nov-Dec;19(6):671-84. doi: 10.3109/01902149309064364.
Enhancement of Pulmozyme activity in purulent sputum by combination with poly-aspartic acid or gelsolin.
Bucki R, Cruz K, Pogoda K, Eggert A, Chin L, Ferrin M, Imbesi G, Hadjiliadis D, Janmey PA.
J Cyst Fibros. 2015 Sep;14(5):587-93. doi: 10.1016/j.jcf.2015.02.001. Epub 2015 Feb 13.
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.
Gkini E, De Soyza J, Spittle DA, Ellis PR, Tearne S, Adab P, Jordan R, Bakerly ND, Turner AM.
BMJ Open Respir Res. 2025 Oct 10;12(1):e003615. doi: 10.1136/bmjresp-2025-003615.
Management of COPD exacerbations.
Evensen AE.
Am Fam Physician. 2010 Mar 1;81(5):607-13.
